image

The best stocks to buy since 1993

Latest issue now available

Dr Martens - An apple for the sole - £10m tariff windfall

July 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Dr. Martens’ decision to appoint Ije Nwokorie - a former Apple executive - as CEO is, I think, a masterstroke. 

But what does a Silicon Valley veteran know about heavy leather boots? Plenty, as it turns out. You see, Apple cracked the code decades ago. Apple’s core genius has always been commodity alchemy: transforming a slab of aluminum and glass into a high-margin necessity and then convincing consumers to shell out four figures for a replacement when it breaks.

Apple is the undisputed master of selling products at eye-watering margins to consumers who insist they cannot live without them. Nwokorie arrived at Dr. Martens two years ago with this mindset fully intact. Shifting focus away from his predecessor’s obsession with opening capital-intensive brick-and-mortar stores, he locked in on brand desire, market heat, and ensuring customers pay full price without flinching. Nwokorie has also injected a distinct confidence regarding the expansion of global wholesale to push the brand deeper into the premium footwear market.

Think about it. A “DM” is basically the iPhone of footwear. It’s got that recognisable appearance - the yellow stitching, which is a bit like the Apple logo of the pavement. It completely transcends fashion. A teenager in Tokyo, a trendy barista in Brooklyn, and a middle-aged man washing his Mondeo on a Sunday in Sutton are all wearing the exact same thing.

It has somehow turned a utilitarian chunk of leather and PVC into an essential, premium lifestyle product. You don’t buy DMs because you need footwear to walk to the shops; you buy them because you insist on having that specific brand on your feet. And with the average customer buying three pairs in a lifetime, it’s the closest thing the fashion world has ever seen to an iphone. It is utterly brilliant. And it means the profit margins are absolutely... colossal.

 

CEO Buys 

The market is yet to agree with me. And the share price chart over the page doesn’t yet reflect the turnaround - having endured a brutal gravity-defying drop from its 2021 pandemic peak of 503p down to the present 70.5p - but I think Nwokorie’s strategy is working. Putting my money where my mouth is, you will have noticed that I almost tripled Growth Portfolio 3’s holding last month. During the month, Nwokorie also acquired 112,500 shares at 76.1p.

Nwokorie’s premium strategy is starting to transform the income statement. In the FY26 full-year results last month, while constant-currency revenue contracted by 1.4% to £765m due to a deliberate reduction in promotional clearance and off-price wholesale activity, profitability reacted sharply. Fewer shoes were sold but more were at full price. Helped by operational cost controls, with non-marketing overheads down 6%, pretax profit was up 61% year-on-year to £55m, with EPS printing at 4.2p, representing a 75% increase over the previous year’s depressed baseline. The gross margins expanded by 120 basis points to 66.2% - a solid lift from the 63.7% margin recorded right after the IPO.

 

Product-wise it’s transformed

To understand what this high-margin strategy looks like on the ground, one only has to look at how the company’s underlying product mix has fundamentally shifted. These days, the classic boots or “DMs” are still the absolute bedrock of the business, accounting for 57% of all sales. But the real magic - the properly clever bit - is happening where the brand is subverting its own heritage.

Take shoes, for example. They have exploded into a standout, growth engine and 19% of sales. And that is entirely fuelled by a massive, global, cultural craving for both the iconic Adrian loafer - which is crafted in buttery, soft Ambassador leather and features a rather lovely signature tassel fringe - and the sleek new Lowell line. Nwokorie’s strategy here is completely intentional: he is expanding the brand’s footprint across all weathers and all occasions, which means you can now wear them when it’s raining, or when it’s sunny, or when you’re simply popping down to the pub.

Concurrently, the summer portfolio has scaled rapidly, with sandals now commanding a chunky 12% share of total revenue. Leading this casual, effortless charge is the breakout Zebzag “family.” It was designed as the ultimate “easy-on” luxury slider, prioritizing pure underfoot comfort, and it now spans everything from mules and sandals to transitional shoes. Alongside it, Nwokorie has unleashed the new Buzz styles, which come with massively chunky platforms that look like they could drive over a reasonably sized dog.

And it doesn’t stop there. Even the accessories are being elevated from mere afterthoughts into high-margin statement pieces. Yes, the basic boot polish and the logo socks are still keeping the registers ringing, but the brand’s premium leather goods are stepping right into the spotlight. They’ve built masterpieces like a structured, rich burgundy Weekender bag - retailing at a cool £310 - helping accessories scale to 9% of sales.

And that proves that a quarter of the future strategy is already materializing.

 

Immersive brand beacons

As well as changing what they are selling, what has also changed is how they are selling it with a total repositioning of the brand’s marketing strategy - the second element of the strategy.

For decades, Dr. Martens’ entire advertising strategy was based around a very narrow, incredibly specific crowd of angry, alternative youth subcultures. It was all a bit exhausting, really. If you weren’t an anti-establishment punk rock bassist or a moody goth who enjoys sitting under piers in January, they didn’t want to know you. Slowly this had expanded into “Style Seekers,” who would buy for current fashion trends.

But today? The message is fiercely, brilliantly inclusive. They’ve launched a massive new global campaign called “With Bouncing Soles,” and it is a masterstroke. Instead of telling you how rebellious you need to be to wear a pair, they are celebrating the actual engineering. They are talking about the legendary, air-cushioned PVC grooved sole. They are highlighting tactile things that normal human beings actually care about - like ultra-supple soft leathers and properly engineered underfoot comfort. By focusing on quality rather than angst, Dr. Martens is successfully recruiting a brand new, highly lucrative, completely mainstream demographic of people who call themselves “Craft Curators” but who are, in reality, just well-off people with sense and who are motivated heavily by product quality, premium craft and comfort. It is securing long-term customer loyalty and unlocking vast sums of cash.

As an extension of this product strategy, out are the basic, stock-stuffed points of sale; in are what Nwokorie refers to as immersive “brand beacons” and “brand centres.” The Brewer Street flagship store in London is the pioneer of this concept, complete with exclusive events, live customisation and an in-store café. It is already delivering average selling prices roughly 15% higher than other London branches despite carrying 60% fewer SKUs. In Seoul, the brand centre format is doing something similar, driving massive basket value simply by making the purchase feel like a destination.

 

From German housewives to punk rock

The Dr. Martens story began in 1945 when Klaus Maertens, a 25-year-old German soldier and doctor, engineered a unique air-cushioned rubber sole out of discarded tires to support his broken ankle. 

By 1947, he and engineer Dr Herbert Funck had a booming business selling these remarkably comfortable shoes. Ironically enough, their core customer base back then consisted of German housewives over the age of 40.  

The true British transformation occurred in 1959 when the Griggs family, multi-generational cobblers out of Wollaston, Northamptonshire, snapped up a license. They entered into an exclusive and perpetual global licensing agreement with the Funck and Maertens families, agreeing to pay them a 2% royalty on everything produced. This royalty is, even now, still accounted for through operating expenses, making the huge margins that Dr. Martens generates all the more amazing.  

The Griggs family tweaked the design, added the iconic yellow welt stitching, the black-and-yellow heel loop, and dubbed the creation “Airwair,” releasing the original 1460 boot  in 1960. 

For decades, the business was a beautifully simple manufacturing and distribution engine, evolving into the anti-establishment armour of punk, grunge and alternative youth subcultures. But corporate reality arrived in 2014 when private equity firm Permira bought it for £300m. What the suits had clocked onto was that Dr. Martens was making two to four times the gross profit per pair of shoes sold directly through e-commerce or retail compared to traditional wholesale channels - equating to roughly £124 after VAT online versus just £50 from a distributor and so they began to open owned stores. The story at the IPO was that the brand would target its efforts in just seven strategic countries - the UK, US, Germany, France, Italy, Japan and China - where it identified a £6bn revenue opportunity. To chase this, it set out to open 25 new physical stores a year.

By the time the company floated on the Full List in January 2021 at 370p per share, sales had raced past £1bn at a frothy pandemic peak, and shares soared over £5. Permira sold down part of its holding but still has a 38.2% stake. The Griggs family has 5%.

 

Organisational overhaul

But as the pandemic-era boot obsession waned, the aggressive own-store expansion left the company exposed to rising operational costs and also high marketing costs. What followed between November 2022 and April 2024 was then a bruising sequence of profit warnings caused by operational self-inflicted wounds. It really was a laundry list of retail nightmares: US wholesale revenues took a severe hit as major accounts choked on excess inventory whilst a doubling of shipping times from the Far East to the US then caused management to over-order stock. 

In 2025, a year into his tenure, Nwokorie made the gut-wrenching call to purge £67m of stagnant inventory to get stock levels back to normal - so that clearance stock from prior years would no longer drag on performance. He also put a total stranglehold on discounted sales and completely axed off-price wholesale deals.

To prevent another catastrophic supply chain cock-up, Nwokorie didn’t just sit around twiddling his thumbs. No. He rolled out a new Customer Data Platform across the whole of Europe and America and overnight, the previously hopelessly vague, regional guesswork was thrown into the skip. In its place is a unified, cross-channel view of exactly what human beings are actually buying.

When you couple that with a truly gargantuan global supply and demand planning system, the boffins at the factory can now track every single boot down to its specific size. It is a data-driven safety net of the absolute highest order. And its job is simple: to ensure that the core, timeless classics - the legendary 1460 boot, the 1461 shoe and the 2976 Chelsea boot, which make up a massive 57% of everything they sell - are always perfectly stocked and never, ever discounted while highly volatile seasonal lines are kept tightly restricted. 

Behind this now sits a significant organizational overhaul where regional corporate layers have been stripped out entirely and replaced with global functions and local general managers. Alongside that, a new tech hub in Bangalore is feeding AI and analytics into everything from demand planning to customer targeting, replacing instinct with data wherever possible.

 

£10m illegal tariff to be repaid!

Of course, while all that was going on, Nwokorie had to contend with a layer of geopolitical drama caused by a deeply concentrated supply chain. Dr. Martens may still be designed in Camden, but 98% to 99% of its physical manufacturing is outsourced to Asia. Five factories in Vietnam account for a massive 65% of cost of goods sold, and two in Laos chip in 30%. 

This concentration turned into an immediate roadblock when US import tariffs on Vietnam jumped to 20% and Laos skyrocketed to 40%. Given that the US accounts for roughly 40% of total group revenues, this could have spelled absolute disaster for gross margins.   

To protect the bottom line, management orchestrated a frantic logistical sprint, intentionally pulling forward shipping schedules to flood stock into US warehouses before the August tariff deadline hit and  Nwokorie and CFO Giles Wilson committed to keeping shelf prices absolutely flat for US consumers through to the end of the calendar year to protect fragile relationships. The mid-term goal, however, is a tactical retreat from Laos-based manufacturing for the US market, shifting the sourcing mix heavily towards Vietnam to exploit its lower tariff rate once the calendar flips. Meanwhile, Donald Trump’s illegal tariff strategy has now been reversed - and Dr. Martens has lodged an application with the US government to get its money back. And we aren't talking about a few loose coins here: £10m is coming.

 

Strict pricing discipline returns to US and Asia

Having ripped up the management chart and thrown the corporate deadwood into a skip, Nwokorie moved on to the final part of his master plan.  

He has looked at the company’s 239 brick-and-mortar shops around the globe, said he won’t be opening new ones for 12-18 months, and decided instead to embrace the wonderful, low-fat world of wholesale. Why? Because running a high-street shop is a financial nightmare. You have to pay rent, electricity and wages. In wholesale the partner absorbs those costs plus the cost of acquiring individual buyers (NB. the 6% reduction seen this year). Bulk order books also create factory cost efficiencies to lower baseline manufacturing costs.

Geographically, however, the world map has split into two very distinct performing halves. The good, and the ugly. In the “good” column, we have America and Asia, where people are happily paying proper, full retail price. The US is doing some seriously heavy lifting here. Full price direct sales are up 14%, and wholesale is staging a magnificent comeback because they’ve stopped dumping cheap stock-slashing bargain volumes by a third, which has dragged average wholesale prices up by a staggering 23%. Over in South Korea, it’s the same story: a 15% jump because they’re showing pricing discipline.

 

Localises management in Europe

Conversely, we have Europe. And Europe is where things are lagging. The UK and Germany are seemingly stuck in a permanent, tight-fisted discount culture. European sales were down by 13% last year. Nwokorie has looked at this mess, admitted the execution was hopeless, and reacted with total, cold-hearted efficiency: he fired the regional bosses, smashed the corporate structure, and installed localised general managers.

Broker Investec expect sales to climb 6%-7% a year, lifting to £813m this year and £860m next.  More importantly, they’re anticipating a monumental rebound in earnings. Pretax profits are expected to rocket to £71.8m this year (EPS 5.5p), before soaring to £90.4m (6.9p) the year after. 

But even better news on the balance sheet. Net bank debt is now just £69.7m, a beautifully safe, perfectly sensible 1.4x EBITDA. And that then, dear reader, is the touch paper. Because right now, Dr. Martens is sitting there looking lean, profitable and cheap and it could only be a matter of time before LVMH, or some other luxury conglomerate, decides to lock in the Permira/Griggs holdings and buy the whole thing. I am a buyer.

 

* The writer has a holding

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author